- Conditions
- Refractory Schizophrenia
- Interventions
- NaBen®, Placebo
- Drug · Other
- Lead sponsor
- SyneuRx International (Taiwan) Corp
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 287 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2026
- U.S. locations
- 1
- States / cities
- Pasadena, California
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–33
of 9
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Schizophrenia
- Interventions
- Cognitive remediation therapy
- Behavioral
- Lead sponsor
- Manhattan Psychiatric Center
- Other
- Eligibility
- 18 Years to 55 Years · Male only
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Schizophrenia
- Interventions
- Olanzapine, Clozapine
- Drug
- Lead sponsor
- Northwell Health
- Other
- Eligibility
- 10 Years to 18 Years
- Enrollment
- 41 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2006
- U.S. locations
- 3
- States / cities
- Dix Hills, New York • Glen Oaks, New York • The Bronx, New York
- Conditions
- Schizophrenia, Schizoaffective
- Interventions
- Riluzole, Placebo
- Drug
- Lead sponsor
- Yale University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2006
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Treatment-resistant Schizophrenia
- Interventions
- Insightec Exablate Neuro MR-guided focused ultrasound transducer
- Device
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 21 Years to 80 Years
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2027 – 2029
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Treatment-resistant Schizophrenia
- Interventions
- Evenamide 15 mg bid, Placebo
- Drug
- Lead sponsor
- Newron Pharmaceuticals SPA
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 5
- States / cities
- Los Angeles, California • Miami, Florida • Atlanta, Georgia + 2 more
- Conditions
- Childhood Onset Psychotic Disorders, Schizophrenia, Psychosis, Mental Disorders
- Interventions
- Electrical Polarization
- Behavioral
- Lead sponsor
- National Institute of Mental Health (NIMH)
- NIH
- Eligibility
- 10 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2015
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Auditory Hallucination, Schizophrenia
- Interventions
- Transcranial direct-current stimulation (tDCS), Placebo
- Device
- Lead sponsor
- Manhattan Psychiatric Center
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2018
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Weight Gain, Sialorrhea
- Interventions
- FazaClo (clozapine, USP) ODT
- Drug
- Lead sponsor
- Azur Pharma, Inc
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 2
- States / cities
- Costa Mesa, California • Gastonia, North Carolina